En face OCT angiography demonstrates flow in early type 3 neovascularization (retinal angiomatous proliferation)

Eye (Basingstoke)

Volumn 29, Issue 5, 2015, Pages 703-706

  Dansingani, K K ^a,b,c   Naysan, J ^a,b,d   Freund, K B ^a,b,d  

^a VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

^b EAR AND THROAT HOSPITAL   (United States)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; ANGIOGENESIS INHIBITOR; BEVACIZUMAB; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AGED; ANGIOGRAPHY; ANGIOGRAPHY DEVICE; ARTICLE; CASE REPORT; EYE PHOTOGRAPHY; FEMALE; HUMAN; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA NEOVASCULARIZATION; RETINAL ANGIOMATOUS PROLIFERATION; RETINAL THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VERY ELDERLY; ANTAGONISTS AND INHIBITORS; BLOOD FLOW; FLUORESCENCE ANGIOGRAPHY; INTRAVITREAL DRUG ADMINISTRATION; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA BLOOD VESSEL; RETINAL NEOVASCULARIZATION;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; BEVACIZUMAB; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INTRAVITREAL INJECTIONS; RANIBIZUMAB; REGIONAL BLOOD FLOW; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84929156942     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2015.27     Document Type: Article

References (8)

1. Hartnett ME, Weiter JJ, Garsd A, Jalkh AE. Classification of retinal pigment epithelial detachments associated with drusen. Graefes Arch Clin Exp Ophthalmol 1992; 230(1): 11-19.
2. Kuhn D, Meunier I, Soubrane G, Coscas G. Imaging of chorioretinal anastomoses in vascularized retinal pigment epithelium detachments. Arch Ophthalmol 1995; 113(11): 1392-1398.
3. Yannuzzi LA, Negrao S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001; 21(5): 416-434.
4. Freund KB, Ho IV, Barbazetto IA, Koizumi H, Laud K, Ferrara D et al. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina 2008; 28(2): 201-211.
5. Nagiel A, Sarraf D, Sadda SR, Spaide RF, Jung JJ, Bhavsar K et al. Type 3 Neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral-domain optical coherence tomography. Retina 2015; e-pub ahead of print 2 February 2015.
6. Jia Y, Tan O, Tokayer J, Potsaid B, Wang Y, Liu JJ et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express 2012; 20(4): 4710-4725.
7. Tokayer J, Jia Y, Dhalla AH, Huang D. Blood flow velocity quantification using split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Biomed Opt Express 2013; 4(10): 1909-1924.
8. Querques G, Souied EH, Freund KB. How has highresolution imaging refined our understanding of the vasogenic process in type 3 neovascularization? Retina 2015; e-pub ahead of print 23 January 2015.